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activities of violacein and starch capped silver
nanoparticles†
Sania Arif,a Aamina Batool,b Nauman Khalid,cd Iftikhar Ahmede
and Hussnain Ahmed Janjua*a
Violacein is a bacterial quorum-sensing chromophore, also referred to as ‘purple treasure’ for its versatile
utility in the pharmaceutical, food, cosmetic and textile industries. Moreover, it provides broad spectrum
biological activity that is the subject of expansive scientiﬁc research. The major limitation in the drug
delivery of violacein is its hydrophobic nature that results in poor bioavailability. Nanoparticles (NPs)
coupled with these drugs tend to enhance their delivery, eﬃcacy and safety proﬁles. In this study, we
established that violacein capped silver NPs (vAgNPs) have shown enhanced stability with 3 to 10 times
higher therapeutic eﬀect against multidrug resistant bacteria, fungi and algae compared to starch
capped silver NPs (cAgNPs). The surface plasmon resonance, size, shape, crystalline nature and capping
agent of these NPs were studied with UV-Vis spectroscopy, Scanning Transmission Electron Microscopy,
Atomic Force Microscopy, X-ray Diﬀraction and Fourier Transform Infrared Spectroscopy, respectively.
This comparative study examines the eﬃcacy of vAgNPs against cAgNPs and establishes that surface
capping of AgNPs with violacein yields conjugative beneﬁts, i.e., strengthening each other's therapeutic
eﬀect, increased bioavailability of violacein, higher stability and maneuvering the therapeutic eﬀect of
vAgNPs towards Gram positive bacteria.Introduction
Violacein, an indole derivative, is synthesized by condensation of
two modied tryptophan molecules and composed of oxindole,
2-pyrrolidone and 5-hydroxyindole subunits.1 This water-
insoluble violet pigment is soluble in acetone, ethanol, meth-
anol and butanol with a maximum absorption at 585 nm.2 Vio-
lacein is also applied in dying synthetic and natural bers.3 It is
a photobleaching-resistant chromophore produced as a quorum-
sensing metabolite by various bacterial strains such as Janthino-
bacterium lividum,2 Chromobacterium violaceum,4 and other
species.5,6 Violacein has shown bactericidal, trypanocidal,, Atta-ur-Rahman School of Applied
e and Technology (NUST), Islamabad,
ust.edu.pk; janjua.hussnain@gmail.com;
ring, National University of Science and
niversity of Management and Technology,
hool of Life and Environmental Sciences,
216, Australia
Pakistan (IMCCP), National Agricultural
bad-45500, Pakistan
tion (ESI) available. See DOI:mycobactericidal, tumoricidal, antiviral and antioxidant activi-
ties.7However, due to its hydrophobic nature, its bioavailability is
compromised, which is a main restraint in its drug delivery.8–10
Nanocarriers are known to not only enhance the eﬃcacy of
drugs but also maneuver its pharmacokinetics.11 Although
diﬀerent kinds of nanoparticles (NPs) have been formulated,
silver nanoparticles (AgNPs) outclass other NPs in terms of their
potential applications ranging from household paint12 to arti-
cial prosthetic devices13 because of their potent antimicrobial,
anticancer and anti-inammatory properties.14–17 Moreover,
their synthesis is eased by using non-toxic and simple reducing
agents such as glucose18 and these AgNPs are stabilized through
surface binding of capping agents, which improves stability,
water solubility and also prevent aggregation.19 AgNPs have also
been capped to deliver therapeutic compounds such as anti-
sense oligonucleotides,20 antitumor,21 antibiotic drugs22 and
many more.10
Drugs and antibiotics resistance is an increasing threat in
the treatment of cancers and pathogenic microbial infections.
Due to repeated and abusive use of drugs, the microbes and
cancer cells have developed resistance against them and even
resistance against AgNPs have been reported.23 Therefore, there
is a need to nd alternative therapies or strengthen the already
existing therapy by conjugating one or more drugs with the
AgNPs. The surface capping of AgNPs with violacein may haveThis journal is © The Royal Society of Chemistry 2017
Fig. 1 Neighbor-joining phylogenetic tree constructed based on 16S
rRNA gene sequence of isolated strains with the closely related validly
published species. The tree was rooted by using Telluria chitinolytica
ACM 3522T (X65590) as an out-group. Bootstrap values (only >60% are
shown) are given at the branching points. Bar indicates 1.0% sequence
divergence.
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View Article Onlineconjugative benets i.e. strengthening each other's therapeutic
eﬀects and increasing the bioavailability of violacein.24,25
This study aimed to evaluate the violacein capped AgNPs
(vAgNPs) as therapeutic agents against starch capped AgNPs
(cAgNPs) in terms of antibacterial, antifungal, antialgal and
anticancer properties. It was observed that antimicrobial
potency of vAgNPs increased from 2 to 10. These vAgNPs
reduce the required dosage against drug resistant microbes and
algae, hence making it possible to eradicate the infections
without causing major cytotoxicity. Other than biomedicine,
their applications lie in cosmetics and paint industries as
sunscreens and antiaging creams due to the absorbance of UV
rays, antioxidant and antimicrobial properties of violacein.
Materials and methods
Identication of violacein producing bacterial strains
The bacterial strains KH3, KH4 and Isl were isolated from the soil
sampled from the Kahuta and Islamabad regions of Pakistan.
The rice grains submerged in themoistened soil samples at room
temperature, showed purple patches of bacterial growth aer 4–5
days. The 16S rRNA gene sequence of the strains was amplied
and sequenced using commercial service of Macrogen Inc. Seoul,
South Korea (http://www.dna.macrogen.com). The strains were
identied based on 16S rRNA gene sequence by comparison with
the sequences of type species on EzTaxon-e server (http://eztaxon-
e.ezbiocloud.net) and BLAST (Basic Local Alignment Search
Tool)26 search on the NCBI (National Center for Biotechnology
Information) server. These sequences were submitted to DNA
Data Bank of Japan (http://www.ddbj.nig.ac.jp/) and are listed in
dendrograms (Fig. 1). Phylogenetic analyses were performed and
molecular evolutionary distances were calculated following the
Kimura 2-parameter model. The alignment and editing was
performed using CLUSTAL X (1.8 msw) and BioEdit.27 The
phylogenetic trees were constructed using three algorithms:
neighbor joining (NJ),28 maximum parsimony (MP)29 and
maximum likelihood (ML)30 using Mega 6 soware.31 The boot-
strap analysis was performed to assess the stability of relation-
ship by performing 1000 re-sampling for the tree topology.
Extraction of violacein pigment
J. lividum strain Islamabad (Isl) was grown in 100 mL of Luria
Bertani (LB) media at 20 C for 5 days and treated for violacein
extraction, according to the methods, described previously.32,33
Bacterial cells were harvested by centrifugation at 13 000 rpm
for 10 min. The supernatant was discarded and cell pallet was
vortexed in 400 mL of 10% sodium dodecyl sulfate (SDS) for 5
days at room temperature. About 900 mL of water-saturated
butanol (1 : 2 (v/v)) was added, vortexed for 5 s and centri-
fuged at 13 000 rpm for 5 min. The upper phase (butanol)
containing the violacein was collected.
Conrmation and quantication of violacein
The extracted pigment contained violacein was conrmed
through UV-Vis spectroscopy at 300 to 700 cm1 on UV-
Spectrophotometer (PG Instruments, Leicestershire, UK).32This journal is © The Royal Society of Chemistry 2017Butanol solution was taken as reference. The extracted pigment
was diluted two times to avoid noise signals. It was further
quantied using maximum optical density (OD585) and the
extinction coeﬃcient of violacein was set at 19.23 mL mM1
cm1. The purity of J. lividum extract was determined using
chloroform and ethanol in 1 : 1 ratio and later, paper chroma-
tography was performed. Aer half an hour, the paper chro-
matogram was dried, and analyzed under UV lamp at 254 nm.Synthesis of violacein capped AgNPs
AgNPs were reduced through glucose, using method previously
explained by Lesli Ortega-Arroyo.18 Briey, 600 mL of 1.7% (w/w)
starch aqueous solution was mixed with 10 mL of 0.1 M AgNO3.
Later 15 mL aliquot of 0.88 M aqueous solution of D-glucose was
added and magnetically stirred for further 3 h. Same protocol
was followed for the synthesis of violacein capped AgNPs, except
4 mL of J. lividium extract solution (violacein concentration: 20
mg mL1) was added in place of starch. In all experiments
deionized water was used for preparing solutions.UV-Vis spectroscopy and purication of AgNPs for
conrmatory studies
The AgNO3 solution presented a pale-yellow color aer 1 min,
indicating the initial formation of AgNPs. The AgNPs were diluted
three times to avoid the noise signals. This was further conrmed
by recording UV-visible spectra on UV-Spectrophotometer asRSC Adv., 2017, 7, 4468–4478 | 4469
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View Article Onlinea function of wavelength from 300–700 nm. AgNO3 solution in
deionized water was taken as reference.
Aer conrmation with UV-Vis spectrophotometry, AgNPs
were centrifuged at 15 000 rpm for 15 min. Supernatant was
discarded and pellet was suspended in deionized water. Steps of
centrifugation and suspension were repeated three times to
remove impurities. In the end, puried colloidal solution of
AgNPs was obtained which was characterized through FTIR,
AFM and SEM to conrm the stability of synthesized AgNPs in
deionized water.
Atomic force microscopy (AFM) and scanning transmission
electron microscopy (STEM)
50 mL of colloidal NPs solution was diluted in almost 5 mL of de-
ionized water and sonication was performed for 1 h. For AFM,
the AgNPs colloidal suspension was dried on silicon wafer in
a desiccator and dried overnight. The surface properties and
size of biosynthesized NPs were visualized by Scanning Probe
Microscopy JSPM-5200 (JOEL, Japan). The scanning was per-
formed in tapping mode. 3D topographical images were ob-
tained. The height, size and particle size measurements of the
AgNPs were made using SPIP 6.2.8 soware.
The violacein and starch capped silver nanoparticles were
deposited onto a copper grid via drop casting method and were
then analyzed using scanning electron microscope (Nova Nano-
SEM 450) operating at 10 kV and working distance of 5 mmusing
STEM detector. The obtained STEM images of AgNPs were then
processed using Image-J soware for their histogram analysis.
Fourier transform infrared spectroscopy (FTIR)
Pellet of KBr was prepared using hydraulic press and 2–3 drops
of violacein and AgNPs were added separately and measure-
ments were carried out using Perkin-Elmer Spectrum-100 FTIR
using scanning wavelength of 450–4000 cm1 with a resolution
diﬀerence of 1 cm1. Manual peak picking method was used for
the analysis of results and the peaks obtained were compared
with standard functional group charts.
X-ray diﬀraction (XRD) studies
The samples were air dried, powdered and used for XRD analysis.
X-ray diﬀraction patterns were recorded in the scanningmode on
WinX'POW, X-ray Diﬀractometer System (STOE: theta/theta,
Germany) operated at 40 kV and a current of 30 mA with Cu
Ka radiation (l ¼ 1.54064 A˚). The diﬀraction intensities were
recorded from 30 to 80, in 2q angles. The diﬀraction intensities
were compared with the standard JCPDS les. The average size of
the NPs can be estimated using the Debye–Scherrer equation:
D ¼ kl/b cos q (1)
where D is the thickness of the nanocrystal, k is the constant, l
corresponds to wavelength of X-rays, b shows width at half
maxima of (111) reection at Bragg's angle 2q and q represent
Bragg angle. Moreover, the size of the AgNPs was made from the
line broadening of the (111), (200), and (220) reection using the
Debye–Scherrer formula through X'Pert High Score Plus soware.4470 | RSC Adv., 2017, 7, 4468–4478Stability prole of AgNPs
The eﬀect of pH, salt, heat and time on AgNPs was assessed
according to the following protocols modied from Naz, et al.34
pH eﬀect. To study the pH eﬀect, 2 mL of freshly prepared
AgNPs was taken and pH was recorded as 7. The pH ranging
from 10–13 was adjusted with 1 M NaOH solution while pH 2–7
was maintained with 1 N HCl. The UV-Vis spectra of resulting
solutions were recorded aer 24 h.
Salt eﬀect. Eﬀect of high concentration of NaCl (2–4 M) on
synthesized AgNPs was studied. For this purpose, 2 mL of 2, 3
and 4 M NaCl solutions were added to 2 mL of freshly prepared
AgNPs. The resulting solution was kept at room temperature for
24 h and its UV-Vis spectrum was recorded.
Heat eﬀect. The eﬀect of heat on synthesized AgNPs was
studied by heating 10 mL of freshly prepared solution up to
100 C for 30 min. The NPs were analyzed for UV-Vis
spectrophotometry.
Age eﬀect. The aging eﬀect of AgNPs was studied aer 4
months of synthesis and compared to the previously synthe-
sized AgNPs through UV-Vis spectrum.Biological activities of synthesized AgNPs
The solution of AgNPs was centrifuged at 15 000 rpm for
15 min, clear supernatant was discarded and dry weight was
calculated. Serial dilutions of AgNPs from the stock solution
were prepared in deionized water and concentrations were
calculated. The concentrations for bioassays prepared were
10 000, 1000, 750, 500, 250, 100, 75, 50, mg mL1.
Antibacterial activity against E. coli, P. aeruginosa and S.
aureus. Multidrug resistant clinical strains of E. coli, S. aureus
and P. aeruginosa were obtained from Phage Lab at Atta-ur-
Rahman School of Applied Biosciences NUST, Pakistan. LB
medium was used for the growth of bacteria's.35 Antibacterial
activity of cAgNPs and vAgNPs was determined with disc diﬀu-
sion method. To avoid false results, Mc Farland Standard of 0.5
turbidity was prepared for adjusting cell density of bacterial
cultures to 1  108 CFUmL1.36 Discs of approximately 6 mm in
size were prepared from Whattman lter paper grade 4, and
were autoclaved. A single disc was placed on the agar inoculated
with the bacterium by using a sterile syringe (BD 5 mL syringe,
REF-305719, Becton & Dickinson, Pakistan), 20 mL of each
dilution of AgNPs and violacein was dispensed and dried onto
the swabbed plates. Plates were incubated overnight at 37 C
and diameters of zone of inhibition at diﬀerent concentrations
were recorded. Each experiment was performed in duplicates.
Negative control of deionized water was used in antibacterial
assay of AgNPs. Butanol, AgNPs and deionized water were also
used as controls. Statistical analysis was carried out for the
estimation of zone of inhibition for duplicate experiment;
average standard deviation was calculated by using Graphpad
Prism 6.0.37 Statistical testing such as paired T test (One Tailed)
was performed to get the p values.
Antifungal activity of AgNPs. Sabouraud dextrose agar
(Oxoid, UK) was used for growth of fungus. 20 L of diﬀerent
dilutions of AgNPs and violacein were poured onto discs. Plates
were incubated at 30 C for 3 days. Each experiment was carriedThis journal is © The Royal Society of Chemistry 2017
Fig. 2 UV-Vis spectrum and chromatogram of crude extract of J.
lividium strain Isl. ( ) Represents the crude extract containing vio-
lacein extracted from J. lividium strain Isl, while ( ) shows the
absorption spectrumof butanol. Themaximum absorbance at 585 nm,
was a characteristic feature of violacein pigment. The inserted image
crude extract having violet pigment due to violacein. The paper
chromatogram shows multiple spots which indicates the presence of
other components along with violacein.
Fig. 3 UV-Vis spectra of AgNPs. The spectrum line marked with
( ) and ( ) corresponds to the UV-Vis spectra of vAgNPs
and cAgNPs respectively. The baseline ( ) shows absorption
spectrum of AgNO3. The inserted image shows (a) AgNO3 observes no
color change while (b) light brown color signiﬁes the synthesis of
cAgNPs and (c) dark brown color indicates the synthesis of vAgNPs.
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View Article Onlineout in duplicates and zones of inhibition were recorded.38
Statistical analysis was carried out for estimation of zone of
inhibition for duplicate experiment; average  standard devia-
tion was calculated by using Graphpad Prism 6.0.37
Anti-algal activity. Basal Bold Media (BBM, Phyto Technology
Laboratories, Australia) was prepared with 1% agarose for
growth of algae. Anti-algal activity was assessed through disc
diﬀusion assay, where 200 mL of BBM, previously incubated with
algae at room temperature and was spread on plates and paper
discs. 20 mL of diﬀerent dilutions were poured onto discs. Latter
plates were incubated at 25 C for 5 days.39 Each experiment was
carried out in duplicates and minimal inhibitory concentration
was analyzed. Statistical analysis was carried out for the esti-
mation of zone of inhibition for duplicate experiment; average
 standard deviation and paired T test (One Tailed) was
calculated using Graphpad Prism 6.0.37
Results and discussion
Identication of isolated strains by 16S rRNA sequencing
Based on 16S rRNA gene sequence analysis, strains KH3, KH4
and Isl were closely related to the cluster of type species: Jan-
thinobacterium lividum (Y08846), J. svalbardensis (DQ355146)
and J. agaricidamnosum (HG322949) and the sequence similarity
for these strains with J. lividum DSM 1522T (Y08846) was found
to be 99.5%, 99.6% and 99.7% respectively, claiming their
species status as J. lividum. A NJ phylogenetic tree showed that
isolated strains clustered coherently with the clade comprising
of strains of the genus Janthino bacterium at high bootstrap
value of 95% (0.1). A similar tree topology of these strains was
also observed with the same species when the phylogenetic
analyses were performed using other algorithms: MP and ML
(Fig. S1 and S2†).
UV-Vis spectroscopy and paper chromatography of crude
extract
Absorption spectrum of crude extract extracted from J. lividium
(Isl) showsmaximum absorption at 585 nm (Fig. 2) and the peak
features are similar with that of violacein extracted from Chro-
mobacterium violaceum (Fig. 2),32 which depicts that violet
pigmentation of J. lividium's extract is due to violacein.
Furthermore, the purity was assessed on paper chromatogram
under UV lamp at 254 nm, which indicated multiple spots and
suggests the presence of other metabolites in addition to vio-
lacein such as deoxyviolacein,40 FK228 (ref. 41) and others.
Synthesis of violacein capped AgNPs
Starch and violacein were used to cap the glucose reduced
AgNPs. Preliminary conrmation of AgNPs synthesis, was
carried out by observing color change in the reaction mixture
from colorless to light brown and nally to yellowish-brown
aer 3 h of stirring. The conrmation in color change and
synthesis of AgNPs was assessed through UV-Vis spectroscopy
(Fig. 3). The position of absorbance peak was in the range of
400 nm to 500 nm indicates the synthesis of AgNPs.42 If
absorption peak with wavelength of AgNPs shis from 400 toThis journal is © The Royal Society of Chemistry 2017500 nm it indicates the particle size increases from 2 to
70 nm.43 Larger sized NPs were formed if the peak wavelength
lies towards red wavelength. In case of vAgNPs the maximum
absorption peak was at 430 nm, compared to that of cAgNPs
(used as control AgNPs in further experiments), the peak lies at
440 nm, showing vAgNPs are relatively smaller sized NPs than
cAgNPs.Atomic force microscopy
Three-dimensional topographical images captured by AFM
verify the assumptions made on the results of UV spectrum that
vAgNPs have smaller diameter than cAgNPs (Fig. 4). Both typesRSC Adv., 2017, 7, 4468–4478 | 4471
Fig. 4 Three dimensional topographical images and histograms of AgNPs. (a) cAgNPs and (b) vAgNPs. The scan size and height was 5.5 mm/8 nm
and 3.5 mm/6 nm for cAgNPs and vAgNPs respectively. The bar at upper right corner represents color change in the scans with the increasing
height. The bar charts represent the histograms of AgNPs where diameter is plotted against percentage abundance.
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View Article Onlineof AgNPs are smooth surfaced, spherical shaped, without any
defects (pinholes or cracks). The topographical images also
agreed that particles are not forming agglomerates, and AgNPs
formed smooth lm on the glass surface. Particle size analysisFig. 5 STEM images of AgNPs, these images were captured at high resolu
cAgNPs and vAgNPs calculated with reference to 500 nm scale.
4472 | RSC Adv., 2017, 7, 4468–4478of each AgNPs showed that cAgNPs are of 1–40 nm diameter and
vAgNPs are of 1–15 nm diameter (Fig. 4) with mean values 19 
9 and 8  4 nm respectively.tion of 500 nm. The sizes of NPs were presented on themicrographs of
This journal is © The Royal Society of Chemistry 2017
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View Article OnlineScanning transmission electron microscopy
STEM images indicate uniform spherical shaped synthesized
AgNPs in colloidal aqueous solution as observed in Fig. 5. The
histograms are coherent with the UV-Vis spectrums, the poly-
dispersed NPs are formed in the range of 3–117 as depicted by
the broad peaks at 430 and 440 nm in the UV-Vis spectrums.
The average size of cAgNps and vAgNPs was calculated to beFig. 6 FTIR studies with AgNPs. (a) FTIR spectra of J. lividium extract. (b
variable functional groups of starch and violacein.
This journal is © The Royal Society of Chemistry 201737 nm greater than 34 nm as predicted in AFM and UV-Vis
spectroscopy.Fourier transform infrared spectroscopy
FTIR measurements were performed to acquire information
about the stabilizing chemical groups present at the surface of
AgNPs.44 In FTIR spectrum of J. lividium extract (Fig. 6a), the IR) FTIR spectrum of cAgNPs and vAgNPs. The peaks correspond to the
RSC Adv., 2017, 7, 4468–4478 | 4473
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View Article Onlinebands at 3364.7 5 cm1, 2924 cm1, 1635 cm1, 1379.17 cm1
and 711 cm1 correspond to the vibrations of functional groups,
N–H overlapping with O–H stretching, C–H, C]O of carbonyl
group. The C–N of indole ring and C–C of aromatic ring was
related to violacein.45,46 This indicates that violacein is present
in J. lividium extract, while presence of other peaks also suggests
that other organic components in extract are a part of it.46
Analysis of cAgNPs indicated capping of starch as the
vibration modes such as skeletal mode vibrations of a-1,4
glycosidic linkage, (C–O–C) 926 cm1, intermolecular bonding
of CO 1405 cm1 and C–C of ring structure 739 etc., refer to
starch.18 In case of FTIR spectra of vAgNPs, violacein was capped
on the surface of AgNPs, as IR bands at 2117.95 cm1,1634
cm1, 1077.15 cm1 and 759 cm1 correspond to the vibrations
of functional groups C]NH+, C]O of carbonyl group, C–N of
indol ring and C–C skeleton vibration of aromatic ring (Fig. 6b)
related to violacein.45,46X-ray diﬀraction
XRD patterns of AgNPs were presented in Fig. 7. Three to four
diﬀraction peaks appear (at 2q) 38, 44, 64 and 77, which
correspond, respectively, to the planes (111), (200), (220), (311),
and (222) of face-centered cubic (fcc); the typical crystallineFig. 7 XRD patterns of AgNPs. (a) cAgNPs and (b) vAgNPs. The sample
was scanned from 0 to 80 degree at angle 2 theta. The labeled peaks
refer to the phases matched with that of typical crystalline phases of
AgNPs.
4474 | RSC Adv., 2017, 7, 4468–4478structure of Ag.18 There were greater number of peaks in vAgNPs
which may due to the capping of violacein and other compo-
nents present in J. lividium extract. The average crystalline size
of cAgNPs and vAgNPs derived from the Debye–Scherrer equa-
tion were 44 nm and 30 nm, which are consistent with the AFM
and STEM results that cAgNPs are larger in size (Table S1†).
Aging and stability prole of AgNPs
The aging and stability prole of AgNPs was assessed under the
inuence of temperature, salt and pH.
Age eﬀect. Aging of AgNPs was observed aer the period of 4
months, cAgNPs began to show the signs of agglomerations as
the peaks were shied from 440 nm to 480 nm (Fig. S3a†).
Additionally, the peak broadening of old cAgNPs showed that
aging also disrupts the monodispersity, i.e. NPs of broad size
range are formed with the passage of time.47 In case of vAgNPs,
the NPs were quite resistant to aging (Fig. S3b†) and as there
was no signicant diﬀerence in peak width and position, this
indicates that violacein capped AgNPs were more stable over
a period and prevent aggregation of AgNPs.
The color change also conrms these ndings, (Fig. S3†), as
in cAgNPs, the color becomes turbid brownish-grey, as
maximum absorbance has shied towards 500 nm and rest of
transmitted wavelengths are perceived as turbid brownish grey
color.47 Similarly, the peak was shied towards red wavelength
and dark brown color appears.
Heat eﬀect. The AgNPs were heated at 60 C for half an h, UV-
Vis spectra showed that cAgNPs were more resistant to heat
(Fig. S4a†). In contrast, the vAgNPs (Fig. S4b†) showed not only
peak shi from 430 nm to 440 nm but also broadening of peak
was observed. This can be due to the susceptibility of metabo-
lites present in J. lividium to the heat.
Salt eﬀect. The agglomerates of AgNPs are formed when their
colloidal solutions were treated with 2, 3 and 4 M of NaCl
(Fig. 8). The peaks were clearly dissolved which signies that
NPs have escaped the nanoscale. Peak shiing from 400 nm to
600 nmwas clear sign of agglomeration. This can be observed in
case of cAgNP, when treated with 2 M NaCl, peak at 440 nm
shied to 580 nm, illustrated the agglomeration of AgNPs
occurs.48 Similar, results were observed with vAgNPs too, the
peak at 430 nm (Fig. 8b) was diminished completely.
pH eﬀect. cAgNPs (Fig. 9a) are more tolerant to pH change,
and survive in pH range 2–10 while vAgNPs are tend to make
agglomerates and exist in short range of pH, 4–10, as violacein
is itself tolerant to short range of pH 5–9.7 Increasing pH also
shi peaks towards 600 nm which was a sign of agglomeration
and peak broadening indicates the increase in the size range of
AgNPs (Fig. 9b). Both AgNPs were most stable at neutral pH 7.
Aer studying stability of vAgNPs and cAgNPs, both AgNPs were
maintained at room temperature, pH 7, diluted with deionized
water and used within a month of their synthesis to assess their
biomedical applications.
Applications of violacein capped AgNPs
Starch itself is non-toxic, biocompatible, and doesn't possess
any antibiological activities,49 therefore cAgNPs were idealThis journal is © The Royal Society of Chemistry 2017
Fig. 8 UV-Vis spectra indicating eﬀect of high concentration of NaCl on AgNPs. (a) cAgNPs and (b) vAgNPs. ( ) Denote absorbance for
untreated samples, ( ) 2 M, ( ) 3 M and ( ) denote absorbance for 4 M.
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View Article Onlinecandidate to be compared with violacein capped AgNPs
(vAgNPs) to assess their antibacterial, antifungal, antialgal and
anticancer activities.Fig. 9 UV-Vis spectra indicating eﬀect of increasing pH on AgNPs.
The inserted images show color change in AgNPs at pH 2–11. cAgNPs
were more tolerant to pH change, and survive in pH range 2–10 while
vAgNPs exist in short range of pH, 4–10. (a) cAgNPs and (b) vAgNPs.
( ) Show absorbance at pH 2, ( ) pH 3, ( ) pH 4, ( ) pH 5,
( ) pH 6, ( ) pH 7, ( ) pH 8, ( ) pH 9, ( ) pH 10 and ( )
denote absorbance at pH 11.
This journal is © The Royal Society of Chemistry 2017Antibacterial activity. vAgNPs showed signicant antibacte-
rial properties, compared to the cAgNPs against all three strains
of E. coli, P. aeruginosa and S. aureus as the p values were <0.05
(Fig. 10a–c). Dose dependent increase in zone of clearance was
observed which indicates that there was directly proportion
relationship between the concentrations of AgNPs, which was
irrespective of the capping components. However, in case of
vAgNPs antibacterial zones were not only bigger but MICs were
also comparatively very low up to 25 mg mL1, indicating
conjugating action between AgNPs and violacein. For all the
three strains of E. coli, MRSA and P. aeruginosa, the MICs for
vAgNPs were 2 to 10 times, 7.5 to 10 times and 4 to 1.3 times less
than cAgNPs respectively. This corresponds to the susceptibility
pattern, S. aureus > P. aeruginosa > E. coli, which indicates that
the capped violacein directs the therapeutic eﬀect of AgNPs
towards Gram positive bacteria, since violacein is more eﬀective
for Gram positive than Gram negative strains.50 MICs of AgNPs
was found to be variable for the diﬀerent strains of each species,
this can be due to the diﬀerences in pan genomes such as silver
resistive genes, which are acquired through horizontal gene
transfer.51
The MICs for crude violacein has been found to be lower up
to 500 ng mL1 than that of puried violacein, 15 mg mL1 (S.
aureus), 15 mg mL1 (P. aeruginosa) and >50 mg mL1 (E. coli),52 it
might be due to the presence of other components such as
deoxyviolacein, oxyviolacein, FK228, etc.53 having antibiological
properties as well.
Antifungal activity. In comparison to antibacterial activity,
there was antifungal activity at high doses of 10 mg and 1 mg of
vAgNPs. cAgNPs didn't show any antifungal activity against
three diﬀerent species even at high concentrations of 10 000
and 1000 mg mL1 (Fig. S5†). Susceptibility for AgNPs, was
found to be variable for the diﬀerent fungal strains, this can be
due to the diﬀerence in cell walls and genomic structure.54,55 In
all strains, vAgNPs found to be eﬀective than cAgNPs. The
overall susceptibility pattern of fungal species against AgNPs
was Aspergillus tamari > Aspergillus tubingensis > Fusarium pro-
liferatum. Remarkable antifungal activity of crude violacein
against all three-fungal species at 5 mg mL1 MIC, also justifyRSC Adv., 2017, 7, 4468–4478 | 4475
Fig. 10 Antibacterial activities against three strains of (a) E. coli (b)
MRSA and (c) P. aeruginosa. The error bars show the standard error of
mean.
Fig. 11 Antialgal activity of AgNPs and crude violacein. The antialgal
activities were conﬁrmed against two other strains Dictyosphaerium
sp. strain DHM 2 (LC159306) and Dictyosphaerium sp. strain DHM 1
(LC159305).
4476 | RSC Adv., 2017, 7, 4468–4478
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View Article Onlinethat due to broad spectrum of extracts of the J. lividium strains
these are eﬀective cutaneous antifungal therapy for amphib-
ians. Since violacein averts mortality andmorbidity caused by B.
dendrobatidis on salamander's skin at about 18 mM concentra-
tion.56 In human pathogens, Trichophyton rubrum, a dermato-
phytic fungi, causes supercial mycoses in skin, nails and hairs,
etc., the MIC of violacein is reported as 32 mg mL1.57
Antialgal activity. vAgNPs showed signicant antibacterial
properties, compared to the cAgNPs against all three species of
algae (Fig. 11). The T-test veried that vAgNPs weremore eﬀective
than cAgNPs (p < 0.05). A dose dependent increase in zone of
clearance was observed which indicates that there was direct
proportional relationship between concentrations of AgNPs and
MICs. The MICs of vAgNPs for Dictyosphaerium sp. strain DHM 1,
Dictyosphaerium sp. strain DHM 2 and Pectinodesmus sp. strain
PHM 3 were 4, 1.3 and 2 times less than cAgNPs respectively,This journal is © The Royal Society of Chemistry 2017
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View Article Onlinewhich indicates that there was strengthening eﬀect at the action
of AgNPs when coupled with crude violacein. Furthermore, the
crude extract also showed signicant antialgal property with 20,
10 and 5 mg mL1 concentration of violacein. The overall
susceptibility pattern of algal species against AgNPs was Dic-
tyosphaerium sp. strain DHM1 >Dictyosphaerium sp. strain DHM2
> Pectinodesmus sp. strain PHM 3.
Conclusion
Numerous studies have been done on green synthesis of AgNPs,
but very few studies give insights to the properties imparted to
the AgNPs by the capping agents. In the present study,
comparative analysis of starch and violacein as capping agents
of AgNPs, in terms of their stability and antibiological proper-
ties was done, to nd out how capping eﬀects the therapeutic
mechanism of AgNPs. The results showed that capping of
AgNPs with violacein, not only enhanced the stability and anti-
microbiological properties of AgNPs. MICs of violacein capped
AgNPs are far lower than starch capped AgNPs, which indicates
the enhanced activity between violacein and AgNPs against
bacteria, fungus, and algae. Moreover, violacein capping also
engineers the therapeutic mechanism of AgNPs, making them
more selective towards Gram positive bacteria. Broad range of
activities against Gram positive and negative bacteria, anti-
fungal, and antialgal activities were well observed and approved
violacein as an impending candidate for biomedicine, drug
delivery and therapeutic mediator.
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